Jul 9 |
Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion
|
Jul 8 |
Mirum (MIRM) Rises More Than 30% in Past 3 Months: Here's Why
|
Jul 8 |
Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
|
Jun 28 |
MercadoLibre, A Few Other Growth Stocks, Among New Faces In IBD 50
|
Jun 28 |
Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
|
Jun 25 |
Biotech Stock Explodes On Drug Trial News As Sales Keep Doubling
|
Jun 18 |
Mirum (MIRM) Soars on Interim Data From Liver Disease Studies
|
Jun 18 |
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
|
Jun 17 |
Mirum stock climbs after positive interim data from liver disease drug
|
Jun 17 |
Mirum Pharmaceuticals Advances after Reporting Positive Trial Results for Prospective Cholangitis Treatment
|